Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 34, Issue 10, Pages 1733-1751
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-08-10
DOI
10.1681/asn.0000000000000189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019
- (2022) Saeid Safiri et al. Frontiers in Endocrinology
- Empagliflozin in Patients with Chronic Kidney Disease
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis
- (2022) Luke E. Barry et al. PLoS One
- Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review
- (2021) Manuel Sanchez-Diaz et al. Journal of Clinical Medicine
- Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
- (2021) Kathleen Pappritz et al. Frontiers in Cardiovascular Medicine
- Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance
- (2020) Neema Negi et al. STEM CELLS
- Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease
- (2020) Christopher D. Wiley Current Diabetes Reports
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
- (2019) Guido Moll et al. TRENDS IN MOLECULAR MEDICINE
- Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
- (2019) Piero Ruggenenti et al. DIABETES OBESITY & METABOLISM
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies
- (2019) Louise Coppin et al. Cells
- Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model
- (2019) Xingxing An et al. Stem Cell Research & Therapy
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
- (2018) Hans-Joachim Anders et al. Nature Reviews Nephrology
- Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
- (2018) Samantha F.H. de Witte et al. STEM CELLS
- Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
- (2018) Norberto Perico et al. Frontiers in Immunology
- Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation
- (2018) Serika D. Naicker et al. Frontiers in Immunology
- The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease
- (2016) Tomás P. Griffin et al. Current Diabetes Reports
- Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
- (2016) Navdeep Tangri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study
- (2016) David K. Packham et al. EBioMedicine
- Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
- (2015) Jay S. Skyler et al. DIABETES CARE
- Excess Mortality among Persons with Type 2 Diabetes
- (2015) Mauro Tancredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
- (2015) Esteban Porrini et al. Lancet Diabetes & Endocrinology
- Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14 ++ CD16 + Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease
- (2014) Kyrill S. Rogacev et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices
- (2014) Deborah D. Ascheim et al. CIRCULATION
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model
- (2013) Shuai Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration
- (2013) Sha-Sha Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy
- (2012) Joshua M. Hare et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sample size calculations for pilot randomized trials: a confidence interval approach
- (2012) Kim Cocks et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies
- (2012) Federica Casiraghi et al. Stem Cell Reviews and Reports
- Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
- (2012) L. von Bahr et al. STEM CELLS
- A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
- (2011) Yashpal S. Kanwar et al. Annual Review of Pathology-Mechanisms of Disease
- A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
- (2011) Navdeep Tangri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nomenclature of monocytes and dendritic cells in blood
- (2010) L. Ziegler-Heitbrock et al. BLOOD
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
- (2009) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of Remission Clinics in the Longitudinal Treatment of CKD
- (2008) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now